Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24729501 | 1.00 | CYP1A2 (0.37) | CYP1A2ATM | |
| SCHEMBL29942062 | 1.00 | CYP1A2 (0.37) | CYP1A2ATM | |
| SCHEMBL24668270 | 0.99 | CYP1A2 (0.38) | CYP1A2ATM | |
| SCHEMBL24729422 | 0.94 | CYP1A2 (0.39) | CYP1A2ATM | |
| SCHEMBL26127961 | 0.94 | CYP1A2 (0.39) | CYP1A2ATM | |
| SCHEMBL24668100 | 0.93 | CYP1A2 (0.38) | CYP1A2ATM | |
| SCHEMBL24667618 | 0.88 | CYP1A2 (0.41) | CYP1A2 | |
| SCHEMBL24668317 | 0.86 | CYP1A2 (0.37) | CYP1A2ATM | |
| SCHEMBL4760067 | 0.85 | CYP1A2 (0.56) | CYP1A2 | |
| SCHEMBL13652118 | 0.85 | CYP1A2 (0.56) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-20230131532-A1 | USE OF MUSK COMPOUNDS IN FLAVORS | PHYTO TECH CORP. | 2023-04-27 | — | — | US | disclosed |
| US-20220298451-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2022-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | MGLL, UGCG, DAGLA | CYP1A2 477/4885ATM 2036/4885 |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CYP1A2 477/4885ATM 2036/4885 |
| US-20220298451-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CYP1A2 477/4885ATM 2036/4885 |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CYP1A2 477/4885ATM 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.